NEW YORK, Nov. 8, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), an innovative, clinical-stage biopharmaceutical company, today announced that a conference call will be held on Tuesday, November 12, 2013 at 8:30 a.m. EST to discuss results for the third quarter 2013 and provide a business outlook for the remainder of the year. Michael Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.
Help employers find you! Check out all the jobs and post your resume.
